Johnson & Johnson
JNJ
Below: live stock price for Johnson & Johnson (JNJ), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Johnson & Johnson (JNJ) trades at 277.54 USD on investpig.
- Prev close
- $275.21
- Volume (24h)
- $319.71M
- Market cap
- $668.84B
- Currency
- USD
Score
Insufficient data
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 279.939 +0.87%
- +20 bars
- 283.2902 +2.07%
- +60 bars
- 284.5974 +2.54%
- +120 bars
- 284.6454 +2.56%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0266 USD.
Interpretation
Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 253 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 18.9%
- Max drawdown
- -11.0%
- Below period high
- -1.3%
- Best day
- +3.99%
- Worst day
- -3.66%
- Up days
- 55%
- Current streak
- 3 up
- Typical day swing
- 1.7%
- Volume vs average
- -13%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 281.07 high → 227.5 low · 60 bars
- ResistanceFib +161.8% extensionnot reached367.7463 USD+32.50% from current
- ResistanceFib +100% extensionnot reached334.64 USD+20.58% from current
- ResistanceFib +61.8% extensionnot reached314.1763 USD+13.20% from current
- ResistanceFib +27.2% extensionnot reached295.641 USD+6.52% from current
- Current277.535 USD
- SupportFib 23.6% retracementNearesttested 10×268.4275 USD-3.28% from current
- SupportFib 38.2% retracementtested 12×260.6063 USD-6.10% from current
- SupportFib 50% midpointtested 11×254.285 USD-8.38% from current
- SupportFib 61.8% retracementtested 5×247.9637 USD-10.65% from current
- SupportFib 78.6% retracementtested 6×238.964 USD-13.90% from current
- SupportFib −27.2% extensionnot reached212.929 USD-23.28% from current
- SupportFib −61.8% extensionnot reached194.3937 USD-29.96% from current
- SupportFib −100% extensionnot reached173.93 USD-37.33% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?Zacks1d ago
- Digital Asset Custody Market Projected to Hit $48.60 Billion by 2035 | SNS InsiderGlobeNewswire1h ago
- AbbVie could take BiTE of Tecvayli market share on Phase III MM winClinical Trials Arena23m ago
- Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities SaysMT Newswires23h ago
- Does Johnson & Johnson (JNJ) Talc Verdict Add To Its Legal Risk?Simply Wall St.1d ago
- Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare SummitBusiness Wire18h ago
- UBS Raises Price Target on Johnson & Johnson to $320 From $280, Keeps Buy RatingMT Newswires1d ago
- Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key FactsZacks1d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,754 USD+1.90%
- 7203.TToyota Motor Corporation3,117 USD-0.51%
- 9984.TSoftBank Group Corp.5,001 USD+1.56%
- 6758.TSony Group Corporation3,895 USD-0.64%
- 6861.TKeyence Corporation77,980 USD-0.05%
- NVDANVIDIA Corporation226.22 USD+0.81%
- AAPLApple Inc.328.995 USD+1.24%
- GOOGLAlphabet Inc.341.6 USD+1.33%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.